303 related articles for article (PubMed ID: 20560105)
1. The Calcium-sensing Receptor (CaR) is involved in strontium ranelate-induced osteoblast differentiation and mineralization.
Takaoka S; Yamaguchi T; Yano S; Yamauchi M; Sugimoto T
Horm Metab Res; 2010 Aug; 42(9):627-31. PubMed ID: 20560105
[TBL] [Abstract][Full Text] [Related]
2. The calcium-sensing receptor (CaR) is involved in strontium ranelate-induced osteoblast proliferation.
Chattopadhyay N; Quinn SJ; Kifor O; Ye C; Brown EM
Biochem Pharmacol; 2007 Aug; 74(3):438-47. PubMed ID: 17531955
[TBL] [Abstract][Full Text] [Related]
3. Strontium ranelate promotes osteoblastic cell replication through at least two different mechanisms.
Caverzasio J
Bone; 2008 Jun; 42(6):1131-6. PubMed ID: 18378206
[TBL] [Abstract][Full Text] [Related]
4. Involvement of calcium-sensing receptor in osteoblastic differentiation of mouse MC3T3-E1 cells.
Yamauchi M; Yamaguchi T; Kaji H; Sugimoto T; Chihara K
Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E608-16. PubMed ID: 15547142
[TBL] [Abstract][Full Text] [Related]
5. Strontium ranelate promotes osteoblastic differentiation and mineralization of murine bone marrow stromal cells: involvement of prostaglandins.
Choudhary S; Halbout P; Alander C; Raisz L; Pilbeam C
J Bone Miner Res; 2007 Jul; 22(7):1002-10. PubMed ID: 17371157
[TBL] [Abstract][Full Text] [Related]
6. Bone morphogenetic protein-2 restores mineralization in glucocorticoid-inhibited MC3T3-E1 osteoblast cultures.
Luppen CA; Smith E; Spevak L; Boskey AL; Frenkel B
J Bone Miner Res; 2003 Jul; 18(7):1186-97. PubMed ID: 12854828
[TBL] [Abstract][Full Text] [Related]
7. Strontium ranelate decreases receptor activator of nuclear factor-ΚB ligand-induced osteoclastic differentiation in vitro: involvement of the calcium-sensing receptor.
Caudrillier A; Hurtel-Lemaire AS; Wattel A; Cournarie F; Godin C; Petit L; Petit JP; Terwilliger E; Kamel S; Brown EM; Mentaverri R; Brazier M
Mol Pharmacol; 2010 Oct; 78(4):569-76. PubMed ID: 20584969
[TBL] [Abstract][Full Text] [Related]
8. Induction of a program gene expression during osteoblast differentiation with strontium ranelate.
Zhu LL; Zaidi S; Peng Y; Zhou H; Moonga BS; Blesius A; Dupin-Roger I; Zaidi M; Sun L
Biochem Biophys Res Commun; 2007 Apr; 355(2):307-11. PubMed ID: 17300752
[TBL] [Abstract][Full Text] [Related]
9. Strontium ranelate prevents the deleterious action of advanced glycation endproducts on osteoblastic cells via calcium channel activation.
Fernández JM; Molinuevo MS; Sedlinsky C; Schurman L; Cortizo AM; McCarthy AD
Eur J Pharmacol; 2013 Apr; 706(1-3):41-7. PubMed ID: 23499695
[TBL] [Abstract][Full Text] [Related]
10. Dual effect of strontium ranelate: stimulation of osteoblast differentiation and inhibition of osteoclast formation and resorption in vitro.
Bonnelye E; Chabadel A; Saltel F; Jurdic P
Bone; 2008 Jan; 42(1):129-38. PubMed ID: 17945546
[TBL] [Abstract][Full Text] [Related]
11. Mouse osteoblastic cell line (MC3T3-E1) expresses extracellular calcium (Ca2+o)-sensing receptor and its agonists stimulate chemotaxis and proliferation of MC3T3-E1 cells.
Yamaguchi T; Chattopadhyay N; Kifor O; Butters RR; Sugimoto T; Brown EM
J Bone Miner Res; 1998 Oct; 13(10):1530-8. PubMed ID: 9783541
[TBL] [Abstract][Full Text] [Related]
12. Ugonin K promotes osteoblastic differentiation and mineralization by activation of p38 MAPK- and ERK-mediated expression of Runx2 and osterix.
Lee CH; Huang YL; Liao JF; Chiou WF
Eur J Pharmacol; 2011 Oct; 668(3):383-9. PubMed ID: 21806985
[TBL] [Abstract][Full Text] [Related]
13. Induction of osteoblast differentiation indices by statins in MC3T3-E1 cells.
Maeda T; Matsunuma A; Kurahashi I; Yanagawa T; Yoshida H; Horiuchi N
J Cell Biochem; 2004 Jun; 92(3):458-71. PubMed ID: 15156558
[TBL] [Abstract][Full Text] [Related]
14. Bone morphogenetic proteins, extracellular matrix, and mitogen-activated protein kinase signaling pathways are required for osteoblast-specific gene expression and differentiation in MC3T3-E1 cells.
Xiao G; Gopalakrishnan R; Jiang D; Reith E; Benson MD; Franceschi RT
J Bone Miner Res; 2002 Jan; 17(1):101-10. PubMed ID: 11771655
[TBL] [Abstract][Full Text] [Related]
15. Constitutive expression of thrombospondin 1 in MC3T3-E1 osteoblastic cells inhibits mineralization.
Ueno A; Miwa Y; Miyoshi K; Horiguchi T; Inoue H; Ruspita I; Abe K; Yamashita K; Hayashi E; Noma T
J Cell Physiol; 2006 Nov; 209(2):322-32. PubMed ID: 16883596
[TBL] [Abstract][Full Text] [Related]
16. Normal matrix mineralization induced by strontium ranelate in MC3T3-E1 osteogenic cells.
Barbara A; Delannoy P; Denis BG; Marie PJ
Metabolism; 2004 Apr; 53(4):532-7. PubMed ID: 15045704
[TBL] [Abstract][Full Text] [Related]
17. Inositol hexakisphosphate inhibits mineralization of MC3T3-E1 osteoblast cultures.
Addison WN; McKee MD
Bone; 2010 Apr; 46(4):1100-7. PubMed ID: 20079473
[TBL] [Abstract][Full Text] [Related]
18. The combination of high glucose and advanced glycation end-products (AGEs) inhibits the mineralization of osteoblastic MC3T3-E1 cells through glucose-induced increase in the receptor for AGEs.
Ogawa N; Yamaguchi T; Yano S; Yamauchi M; Yamamoto M; Sugimoto T
Horm Metab Res; 2007 Dec; 39(12):871-5. PubMed ID: 17960513
[TBL] [Abstract][Full Text] [Related]
19. In vitro effects of strontium ranelate on the extracellular calcium-sensing receptor.
Coulombe J; Faure H; Robin B; Ruat M
Biochem Biophys Res Commun; 2004 Oct; 323(4):1184-90. PubMed ID: 15451421
[TBL] [Abstract][Full Text] [Related]
20. Alendronate induces mineralization in mouse osteoblastic MC3T3-E1 cells: regulation of mineralization-related genes.
Inoue Y; Hisa I; Seino S; Kaji H
Exp Clin Endocrinol Diabetes; 2010 Nov; 118(10):719-23. PubMed ID: 20213600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
